PBYIPUMA BIOTECHNOLOGY, INC.vs its industry peers
A metric-by-metric comparison of PUMA BIOTECHNOLOGY, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PBYIThis | $396M#9 | 16.2x#2 | 3.1x#10 | 1.7x#4 | -0.9%#6 | 2.8%#6 | 16.3%#1 | 24.2%#1 | 31.3%#1 | — | 149.6%#2 | — |
| AQST | $458M#3 | — | — | 10.3x#7 | -22.6%#8 | -89.8%#11 | -159.5%#7 | — | — | — | -4.7%#11 | — |
| IMMX | $453M#4 | — | 5.4x#12 | — | — | -36.0%#10 | — | -34.8%#7 | — | — | 202.7%#1 | — |
| BIOA | $436M#5 | — | 1.2x#2 | 48.5x#10 | — | -13.4%#9 | -1031.5%#9 | -21.3%#4 | -67.0%#6 | — | 121.6%#4 | — |
| AVTX | $980M#1 | — | 14.3x#13 | 16616.1x#13 | -86.6%#10 | -122.8%#14 | -123601.7%#12 | -114.5%#13 | -124.4%#8 | — | 139.1%#3 | — |
| PRTA | $420M#6 | — | 1.3x#4 | 43.4x#9 | -92.8%#11 | -99.6%#12 | -2216.4%#11 | -78.1%#11 | — | — | 16.7%#8 | — |
| EVMN | $398M#8 | — | 1.3x#3 | 30.6x#8 | 85.7%#4 | -3.1%#8 | -623.6%#8 | -22.6%#5 | — | — | — | — |
| ASMB | $399M#7 | 313.5x#3 | 2.0x#7 | 5.5x#5 | 153.5%#2 | 84.8%#2 | -16.8%#4 | -3.1%#3 | -7.2%#3 | — | 39.3%#6 | — |
| LRMR | $392M#10 | — | 2.5x#9 | — | — | -105.5%#13 | — | -104.8%#12 | — | — | 9.1%#9 | — |
| EOLS | $378M#11 | — | — | 1.3x#3 | 11.6%#5 | -2.4%#7 | -11.0%#3 | — | -42.0%#4 | 3#2 | — | — |
| AVIR | $378M#12 | — | 1.6x#5 | 1.1x#2 | 622.5%#1 | 6.0%#5 | -51.5%#5 | -67.6%#9 | — | — | — | — |
| ENTA | $368M#13 | — | 3.2x#11 | 5.6x#6 | -3.4%#7 | 29.4%#3 | -130.7%#6 | -70.2%#10 | — | — | 67.4%#5 | — |
| EBS | $365M#14 | — | 0.7x#1 | 0.5x#1 | -28.8%#9 | 127.6%#1 | 13.5%#2 | 10.1%#2 | 6.8%#2 | 7#1 | 20.2%#7 | — |
| ALT | $546M#2 | — | 1.9x#6 | 13304.9x#12 | 105.0%#3 | 7.3%#4 | -230461.0%#13 | -31.0%#6 | -42.6%#5 | — | -23.9%#12 | — |
| ABEO | $357M#15 | 6.6x#1 | 2.5x#8 | 61.4x#11 | — | -211.7%#15 | -1536.9%#10 | -49.1%#8 | -101.1%#7 | — | -1.8%#10 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice